Does remifentanil attenuate renal ischemia–reperfusion injury better than dexmedetomidine in rat kidney?

Ezgi Erkılıç, Elvin Kesimci, Ferit Alaybeyoglu, İbrahim Kılınç, Rabia Tural, Aylin Kılıç Yazgan, Tülin Gümüş, Aylin Sepici Dinçel, Gurkan Dumlu, Orhan Kanbak

Drug Design Development and Therapy · 2017 · 17 citations · 35 references

DOIFull text

Open access

Abstract

The NGAL levels and histopathological findings reflected protection by dex against renal I/R injury. However, the same exact results could not be mentioned for remifentanil depending on our study results.

References

35